Latest Advancement in Minimally Invasive Glaucoma Surgery
Ludwick Eye Center is excited to announce that we are offering the XEN Gel Stent, the latest advancement in Minimally Invasive Glaucoma Surgery (MIGS). This implant is designed to lower eye pressure in patients with open angle glaucoma where medications alone were insufficient or previous surgical treatment has failed.
The XEN Gel Stent works by creating a small channel in the eye that drains fluid, therefore reducing the eye pressure to a normal level and helping to preserve vision. Clinical studies have shown that at 12 months patients used, on average, less glaucoma medications than they did before XEN was implanted. This Minimally Invasive Glaucoma Surgery offers patients the advantage of better control of their glaucoma as well as likely reducing the need for costly glaucoma medication.